Granules India’s Independent Director Arun Rao Akinepally Retired

Arun Rao Akinepally is completing his second term as Independent Director of Granules India Limited on March 31, 2024, and will cease to be an Independent Director of the company thereafter.

Arun Rao Akinepally serves as the Managing Director of Akin Laboratories Private Ltd. He possesses extensive expertise in the finished dosage sector and technical operations. Additionally, he holds positions on the Boards of ESPI Industries, Chemicals Private, and Sanzyme. He has held significant roles within the Indian Pharmaceutical Association at both the central and state levels. He holds a B.Tech in Chemical Engineering from the University of Madras and an MS from the Illinois Institute of Technology, Chicago, USA.

In a communication to the stock exchanges, the company has announced that Sethu Madhavan Sankaran has been appointed as Senior Vice President, API Manufacturing and Operations, with effect from March 29, 2024, and has been designated as one of the SMPs of the company.

Sethu Madhavan is an M.Tech. (Chemical Engineer) from ICT and brings 27 years of experience in manufacturing and operations. He is a results-driven leader experienced in spanning diverse industries, including Petrochemical, Pharmaceutical, and Biopharma Technology, the company said. Before joining Granules India, he worked with leading organisations like Biocon Biologics Ltd., Teva API, Ranbaxy, Dr. Reddy’s, and Herdillia Chemicals. In his last assignment, he was associated with Biocon Biologics Ltd. as a Global Head of Operations for the Insulin business.